EMPIRE CONSULTING GROUP

Lobbying for VERTEX PHARMACEUTICALS INCORPORATED · Biotechnology company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $50,000.00 income · posted Jul 16, 2026

Bills named in this filing 1

Lobbying activity 1

Health Issues

Issues related to HR 1227, Alternatives to Pain Act

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.